Body composition assessment for the definition of cardiometabolic risk.
Open accessThe DOI matches its OpenAlex record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Obesity is associated with a major prevalence of cardiovascular risk factors and high risk of cardiovascular events and contributes to the increase in cardiovascular morbidity and mortality worldwide. Beyond the fat mass per se, the pattern of fat distribution has a profound influence on cardiometabolic risk. The increase in abdominal adipose tissue confers an independent risk, while the amount of gluteofemoral body fat is thought to be protective. Changes in the capacity of different depots to store and release fatty acids and to produce adipocytokines are important determinants of fat distribution and its metabolic consequences. Because of the complexity of the assessment of body fat with imaging techniques, great attention has been paid to other measures of adiposity, such as waist circumference (WC), waist-to-hip ratio (WHR), and waist-to-height ratio (WHtR), which provide information on body fat distribution, although body mass index (BMI) is the established clinical measure to estimate the cardiovascular risk disease associated with excessive body weight. Abdominal obesity is a main predictive factor of the metabolic syndrome, so it is certain that it represents a better marker of cardiovascular risk than BMI. Visceral adiposity index (VAI) has recently proven to be a marker of visceral adipose distribution and function, associated with insulin sensitivity in patients at metabolic risk; however, the evidence needs to be further confirmed. In summary, BMI, WC, WHR, WHtR, and VAI are all useful tools for assessing adiposity/ obesity in clinical practice, and should be evaluated along with other cardiometabolic risk factors to define cardiovascular risk stratification.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026
Abdominal obesity and metabolic syndrome
Després, J.-P., & Lemieux, I. (2006) · Nature · doi:10.1038/nature05488 · Cited by 4,354 · cited 1×
“Obesity is considered the most important predisposing factor for type 2 diabetes mellitus and cardiovascular disease (1).”
BackgroundSubcutaneous and visceral adipose tissue: their relation to the metabolic syndrome
Wajchenberg, B. L. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.6.0415 · Cited by 2,961
Yusuf, S., Hawken, S., Ôunpuu, S., Bautista, L., Franzosi, M. G., Commerford, P., Lang, C. C., Rumboldt, Z., Onen, C. L., Lisheng, L., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67663-5 · Cited by 2,903
A transgenic model of visceral obesity and the metabolic syndrome
Masuzaki, H., Paterson, J., Shinyama, H., Morton, N. M., Mullins, J. J., Seckl, J. R., & Flier, J. S. (2001) · Science · doi:10.1126/science.1066285 · Cited by 1,766 · cited 1×
“In particular, the increase in visceral adipose tissue (VAT) is linked to insulin resistance, dyslipidemia, low grade inflammation, diabetes, hypertension and cardiovascular disease (2-14).”
BackgroundAmato, M. C., Giordano, C., Galia, M., Criscimanna, A., Vitabile, S., Midiri, M., Galluzzo, A., & for the AlkaMeSy Study Group (2010) · Diabetes Care · doi:10.2337/dc09-1825 · Cited by 1,751
Self-citationBrowning, L. M., Hsieh, S. D., & Ashwell, M. (2010) · Nutrition Research Reviews · doi:10.1017/s0954422410000144 · Cited by 1,400 · cited 1×
“Interest in the effectiveness of this measurement is still rising for both adults and children in many different ethnic groups (39-44).”
BackgroundLee, C. M. Y., Huxley, R. R., Wildman, R. P., & Woodward, M. (2008) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2007.08.012 · Cited by 1,173
Carr, D. B., Utzschneider, K. M., Hull, R. L., Kodama, K., Retzlaff, B. M., Brunzell, J. D., Shofer, J. B., Fish, B. E., Knopp, R. H., & Kahn, S. E. (2004) · Diabetes · doi:10.2337/diabetes.53.8.2087 · Cited by 993
The metabolically obese, normal-weight individual revisited.
Ruderman, N., Chisholm, D., Pi-Sunyer, X., & Schneider, S. (1998) · Diabetes · doi:10.2337/diabetes.47.5.699 · Cited by 893
Cited by
Maharlouei, N., Tabrizi, R., Lankarani, K. B., Rezaianzadeh, A., Akbari, M., Kolahdooz, F., Rahimi, M., Keneshlou, F., & Asemi, Z. (2019) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2018.1427044 · Cited by 99
“Introduction Obesity is defined as excessive fat accumulation which is a public health concern during recent decades (Amato et al. 2013).”
BackgroundDurmus, U., Duran, C., & Ecirli, S. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0582-x · Cited by 87
“It is also known that the assessment of central/visceral adiposity is a better evaluation, compared to the assessment of overall obesity in predicting cardiovascular disorders (CVDs) [11].”
BackgroundGrabež, M., Škrbić, R., Stojiljković, M. P., Rudić-Grujić, V., Paunović, M., Arsić, A., Petrović, S., Vučić, V., Mirjanić-Azarić, B., Šavikin, K., et al. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2019.103692 · Cited by 85
Is diabetes in Cushing’s syndrome only a consequence of hypercortisolism?
Giordano, C., Guarnotta, V., Pivonello, R., Amato, M. C., Simeoli, C., Ciresi, A., Cozzolino, A., & Colao, A. (2014) · European Journal of Endocrinology · doi:10.1530/eje-13-0754 · Cited by 79
Self-citationHolmboe, S. A., Vradi, E., Jensen, T. K., Linneberg, A., Husemoen, L. L. N., Scheike, T., Skakkebæk, N. E., Juul, A., & Andersson, A.-M. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2460 · Cited by 63
“Furthermore, the association between low T and increased CVD mortality was observed when we used BMI as a confounder to adjust for obesity, but became insignificant when instead we used waist circumference, an alternative anthropometric measure of obesity (32).”
Method
Metadata
- Authors
- Amato, M. C., Guarnotta, V., & Giordano, C. S. D. S.
- Venue
- PubMed
- Publisher
- National Institutes of Health
- Published
- 2014-03-18
- Volume
- 36
- Issue
- 7
- Pages
- 537-43
- DOI
- 10.3275/8943
- OpenAlex
- W2162461117
- Cited by
- 128
- References
- 16
- FWCI
- 7.97
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.